Virology
A section of Microorganisms (ISSN 2076-2607).
Section Information
Viruses represent a significant part of the microbial universe, and they are the causative agents of many diseases impacting the global public health landscape. This section is dedicated to significant findings about viruses of animals, plants, insects, and bacteria. With the expanding number of viral spill-over events and the increase in vaccine hesitancy in many parts of the world, research on “old” and newly emerging viral diseases is welcome.
Viruses require a host for propagation and dissemination, so the elucidation of the virus–host interface is critically important. Genetic manipulation and molecular characterization of viruses through in vitro and cell culture experiments helps to form the needed foundation for advanced studies. Animal model development is generally used to expand our understanding of disease and pathology and is a necessity for the evaluation of vaccines and therapeutics. In addition, ecological aspects—such as the search for viral reservoirs—cannot be ignored. We encourage the submission of manuscripts from all areas of basic and translational virology that expand our understanding of viral transmission, molecular virology, animal models, pathogenesis, and countermeasure development.
In this section, original and review articles reporting state-of-the-art developments and covering basic and applied aspects of virology are welcome. Articles that are outside the scope of the subject matter listed here may be referred to another section of Microorganisms.
Keywords
- Antivirals and vaccines
- Cell biology
- Chronic/persistent viral diseases
- Detection and diagnosis
- Disease and viral pathogenesis
- Ecology
- Emerging and neglected viruses/viral diseases
- Epidemiology and public health
- Host response
- Host–virus interactions
- Immunology
- Laboratory methods
- Molecular virology
- Pathology
- Phylogenetics and molecular genetics
- Preclinical studies
- Viral lifecycle and particle morphology
- Virus evolution
- Zoonotic diseases
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Control and Elimination of Viral Hepatitis (Deadline: 30 September 2023)
- SARS-CoV-2/COVID-19 Infection: Molecular and Clinical Aspects (Deadline: 30 September 2023)
- Hepatocellular Carcinoma: Where Viral Hepatitis Meets Other Aetiologies (Deadline: 30 September 2023)
- Control of Viral Infections: Pathogenesis, Immunity, Vaccines and Antivirals (Deadline: 30 September 2023)
- COVID-19/SARS-CoV-2: Infection, Vaccination and Immune Response (Deadline: 20 October 2023)
- Arboviruses 2.0 (Deadline: 31 October 2023)
- Advances in Viral Metagenomics (Deadline: 31 October 2023)
- Advances in Human Rhinovirus Infections (Deadline: 31 October 2023)
- Hepatitis E Virus (HEV) and Other Hepeviridae (Deadline: 31 October 2023)
- Viruses and Endocrine Diseases (Deadline: 31 October 2023)
- The Microbiome/Virome Interface of COVID-19 (Deadline: 31 October 2023)
- Coronaviruses: Genomic Surveillance and Control Strategies (Deadline: 1 November 2023)
- Testing Strategies for SARS-CoV-2 Variants Surveillance: Epidemiological, Clinical and Future Implications (Deadline: 15 November 2023)
- Exploring New Approaches for Human Cytomegalovirus Inhibition (Deadline: 30 November 2023)
- Adeno-Associated Virus Biology and AAV Vector-Mediated Gene Therapy (Deadline: 30 November 2023)
- Advances in SARS-CoV-2 Infection 2.0 (Deadline: 30 November 2023)
- Advances in African Swine Fever Virus (Deadline: 30 November 2023)
- Herpes Simplex Virus (HSV) (Deadline: 30 November 2023)
- Mathematical Modeling and Simulation of Viral Infections (Deadline: 30 November 2023)
- The Emergence and Escape of SARS-CoV-2 Variants: Molecular Perspectives (Deadline: 30 November 2023)
- Diagnostics and Antivirals for Emerging Viruses (Deadline: 10 December 2023)
- Clinical Viral Infections and Autoimmunity (Deadline: 10 December 2023)
- Common Clinical Viral Pathogens: Detection and Treatment (Deadline: 29 December 2023)
- Epstein–Barr Virus Infection and Associated Diseases 2.0 (Deadline: 30 December 2023)
- New Knowledge in the Study of Coronaviruses: Towards One Health and Whole Genome Sequencing Approaches (Deadline: 31 December 2023)
- Emerging Arthropod-Borne Viruses in Changing Environments (Deadline: 31 December 2023)
- Emerging Viral Zoonoses (Deadline: 31 December 2023)
- Coxsackievirus Infection and Associated Diseases 2.0 (Deadline: 31 December 2023)
- Late Presentation to HIV Care (Deadline: 31 December 2023)
- Cross-Kingdom Infections by Diverse Viruses between Fungi and Other Kingdoms (Deadline: 31 December 2023)
- Coronaviruses: Past, Present, and Future (Deadline: 31 December 2023)
- Innovative Antiviral Approaches and New Molecular Targets against Viral Infections (Deadline: 15 January 2024)
- Animal Virology, Molecular Diagnostics and Vaccine Development (Deadline: 31 January 2024)
- Recent Advances in Antivirals for Emerging Viruses 3.0 (Deadline: 31 January 2024)
- Microorganisms and Diseases Associated with Aquatic Animals 2.0 (Deadline: 15 February 2024)
- Climate Change and Emerging Arboviruses (Deadline: 15 February 2024)
- Emerging Viruses: New Challenges in Detection, Prevention and Control (Deadline: 15 February 2024)
- Ecology of Influenza A Viruses 2.0 (Deadline: 28 February 2024)
- COVID-19 Infection and Neurological Disorders: From Observational Studies to Mechanisms (Deadline: 29 February 2024)
- Emerging Viruses and Antiviral Drugs 2.0 (Deadline: 31 March 2024)
- Molecular Mechanisms of Viral Persistence and Immune Evasion (Deadline: 30 April 2024)
